ALZpath, Inc.

Apr 07, 2025

ALZpath Named 2025 BRONZE Edison Award Winner for its Proprietary pTau217 Antibody, a Key Biomarker Driving Blood-Based Alzheimer's Disease Diagnostics

Mar 25, 2025

ALZpath Adds Biotech Veteran to Board of Directors and Names Prominent Global Researcher as Distinguished Scientific Advisor

Oct 30, 2024

ALZpath Proprietary pTau217 Antibody Named to TIME'S List of the Best Inventions of 2024

Jul 29, 2024

New Data Presented at AAIC 2024 Demonstrates High Accuracy of Blood Tests Incorporating ALZpath Proprietary pTau217 Antibody for Alzheimer's Disease Diagnosis

Jul 15, 2024

ALZpath Signs Licensing Agreement with Beckman Coulter Diagnostics to Provide Proprietary pTau217 Antibody to Develop a Diagnostic Blood Test for Alzheimer's Disease

Jun 10, 2024

ALZpath Announces Licensing Agreement with Roche for Use of ALZpath's Proprietary pTau217 Antibody in Blood Test to Diagnose Alzheimer's Disease

May 02, 2024

TIME Selects ALZpath Co-Founder Dr. Venkat Shastri As Inaugural Member of Time100 Health Ranking

Jan 22, 2024

New Study Published in JAMA Neurology Affirms High Diagnostic Accuracy of ALZpath's pTau217 Test in Identifying Amyloid and Tau in the Brain